{"disease":{"id":"pneumonia-caused-by-severe-acute-respiratory-syndrome-coronavirus-2","name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"baricitinib","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Olumiant","generic_name":"baricitinib","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Tyrosine-protein kinase JAK2","drug_class":"Janus Kinase Inhibitor [EPC]","quality_score":50,"revenue":"1200","mechanism":""},{"drug_id":"olumiant","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Olumiant","company_name":"NHS Greater Glasgow and Clyde","drug_phase":"marketed","molecular_target":"Casein kinase I isoform gamma-1, Citron Rho-interacting kinase, Mitogen-activated protein kinase kinase kinase 1","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"tocilizumab","indication_name":"Pneumonia caused by Severe acute respiratory syndrome coronavirus 2","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Roactemra","generic_name":"tocilizumab","company_name":"Roche","drug_phase":"marketed","molecular_target":"Interleukin-6 receptor","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":10,"revenue":null,"mechanism":"Roactemra works by blocking the interleukin-6 receptor, a protein that plays a key role in inflammation."}],"pipeline":[],"offLabel":[],"totalMarketed":3,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05115045","title":"Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 Patients","phase":"","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Hopital of Melun","has_results":false}],"total":1},"guidelines":[{"drug_id":"baricitinib","guideline_body":"FDA label","recommendation":"Baricitinib is indicated for the treatment of hospitalized adults requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) due to COVID-19.","line_of_therapy":"any","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}